Immunotherapy of Cancer: Present Status of Trials in ManWilliam D. Terry, Dorothy Windhorst |
Contents
Diagnosis Prognosis and Con | 1 |
A Controlled Study of Adjuvant Therapy in Patients with Stage I | 19 |
Surgical Adjuvant Immunotherapy with BCG in Patients with Malig | 27 |
Copyright | |
62 other sections not shown
Common terms and phrases
acute leukemia adenocarcinoma administration allogeneic analysis antigens Bacillus Calmette-Guerin breast cancer Cancer Center carcinoma chemo Chemoimmunotherapy compared complete remission control group cyclophosphamide daunorubicin difference disease disease-free interval DNCB dose doxorubicin doxorubicin hydrochloride DTIC edited by W. D. effect evaluable follow-up group of patients Gutterman Hersh histologic historical control I-RNA immune immunological immunotherapy induction injection Institute intradermal intravenous lesions levamisole lung cancer lymph nodes lymphocytes lymphoma M. D. Anderson M. D. Anderson Hospital maintenance chemotherapy malignant melanoma Mathé Mavligit median survival MER-BCG metastases methotrexate mg/m² months myeloblastic number of patients Oncology oncolysate osteogenic sarcoma osteosarcoma parvum patients receiving patients treated percent primary prognosis prolonged protocol randomized reactions recurrence regimen relapse remission duration reported resection response rate skin test stage statistically significant surgery surgical survival curves Table therapeutic tients tion toxicity treatment tumor tumor cells vaccine vincristine W. D. Terry weeks Windhorst